Correction to: Scientific Reports https://doi.org/10.1038/srep27911, published online 15 June 2016
This Article contains errors.
For Fig. 6C, the lanes shown for JNK are incorrect. The correct Fig. 6 and accompanying legend appear below.
Figure 6.
Effects of ACE2 and different treatments on the phosphorylation of MAPKs in lung tissue. LPS exposure caused a marked increase of the phosphorylation levels of p38 MAPK (A), ERK1/2 (B) and JNK (C), which was significantly suppressed by ACE2 overexpression in rat lung. Pretreatment with A779 or MLN-4760 completely abolished the inhibitory effects of ACE2 overexpression on LPS-induced p38 MAPK and ERK1/2 phosphorylation, but did not affect the level of JNK phosphorylation. ACE2 RNAi in rat lung significantly enhanced the LPS-induced ERK1/2 and JNK phosphorylation but did not change p38 MAPK phosphorylation. Data are represented as mean ± SD. *p < 0.05, versus control group; #p < 0.05, versus LPS group; $p < 0.05, versus ACE2 group (n = 6, per group).
In addition, full blots for the data presented were omitted in the original Article. They have been included in the attached Supplementary Information file.
Supplementary Information
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-022-09404-5.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.